Fiber types, asbestos potency, and environmental causation: A peer review of published work and legal and regulatory scientific testimony

International Journal of Occupational and Environmental Health

Volumn 15, Issue 2, 2009, Pages 202-228

  Egilman, David ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Asbestos; Chrysotile; Litigation; Mesothelioma; Peer review; Public policy

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EPIDEMIOLOGY; FEMALE; HUMAN; LUNG TUMOR; MESOTHELIOMA; METHODOLOGY; MIDDLE AGED; PEER REVIEW; POLICY;

ADULT; AGED; ASBESTOS; BIAS (EPIDEMIOLOGY); ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MIDDLE AGED; PEER REVIEW; PUBLIC POLICY; SEER PROGRAM;

EID: 67651043427     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2009.15.2.202     Document Type: Note

References (187)

1. JAMA Editor Calls Critic a 'Nobody and a Nothing.' 2009. [cited 2009 March 3] Available from: http://blogs.wsj.com/health/ 2009/03/13/jama-editor- calls-critic-a-nobody-and-a-nothing/.)
2. Winstein K, Armstrong D. "Top Pain Scientist Fabricated Data in Studies", Hospital Says. Wall Street Journal. 2009 Mar11,2009. 3. Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299:2391-400.
3. DeAngelis CD, Fontanarosa PB. Conflicts Over Conflicts of Interest. JAMA 2009;301:2.
4. Robinson RG, Arndt S. Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression. JAMA. 2009;301:1023-4.
5. Azuma K, Uchiyama I, Chiba Y, Okumura J. Mesothelioma Risk and Environmental Exposure to Asbestos; Past and Future Trends in Japan. Int J Occup Environ Health. 2009;15:6.
6. Hessell P. Inaccuracies in Article on Mesothelioma in Brake Workers [Letter]. Int J Occup Environ Health. 2009;15.
7. Welch L, Anderson HA, Balmes J, et al. Research on Mesothelioma from Brake Exposure: Corporate Influence Remains Relevant Concern [Letter]. Int J Occup Environ Health. 2009;15.
8. Mark EJ, Yokoi T. Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure. Ann N Y Acad Sci. 1991;643:196-204.
9. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med. 1998;338:1565-71.
10. Egilman D, Fehnel C, Bohme SR. Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med. 2003;44:540-57.
11. Gustavsson P, Nyberg F, Pershagen G, et al. Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden. Am J Epidemiol. 2002;155:1016-22.
12. Pan XL, Day HW, Wang W, et al. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172:1019-25.
13. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107-12.
14. Teta MJ, Mink PJ, Lau E, et al. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17:525-34.
15. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145:211-8.
16. Patel AV, Bogner PN, Klippenstein D, Ramnath N. Malignant pleural mesothelioma after household exposure to asbestos. J Clin Oncol. 2008;26:5480-3.
17. Miller A. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990. Am J Ind Med. 2005;47:458-62.
18. Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med. 2002;41:188-201.
19. Castleman BI, Berger SL. Asbestos : medical and legal aspects. 5th ed. New York, NY: Aspen Publishers; 2005.
20. Schneider J, Rodelsperger K, Bruckel B, et al. Pleural mesothelioma associated with indoor pollution of asbestos. J Cancer Res Clin Oncol. 2001;127:123-7.
21. Schneider J, Straif K, Woitowitz HJ. Pleural mesothelioma and household asbestos exposure. Rev Environ Health. 1996;11:65-70.
22. Health and Safety Executive. Mesothelioma Occupation Statistics: Male and Female Deaths Aged 16-74 in Great Britain. Suffolk: HSE Books; 2006.
23. Egilman DS, Billings MA. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. Int J Occup Environ Health. 2005;11:360-71.
24. Seidman H, Selikoff IJ, Hammond EC. Short-term asbestos work exposure and long-term observation. Ann N Y Acad Sci. 1979;330:61-89.
25. Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369:844-9.
26. Welch LS. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health. 2007;13:318-27.
27. Welch LS, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health. 2005;11:254-8.
28. Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: A spatial case-control study in the city of Bari (Italy). Int Arch Occup Environ Health. 2009;82:489-97.
29. Berry M. Mesothelioma incidence and community asbestos exposure. Environ Res. 1997;75:34-40.
30. Greenberg M, Davies TA. Mesothelioma register 1967-68. Br J Ind Med. 1974;31:91-104.
31. Mollo F, Magnani C. European multicentric case control study on risk for mesothelioma after non-occupational (domestic and environmental) exposure to asbestos. Med Lav. 1995;86:496-500.
32. Magnani C, Ivaldi C, Botta M, Terracini B. Pleural malignant mesothelioma and environmental asbestos exposure in Casale Monferrato, Piedmont: Preliminary analysis of a case-control study. Med Lav. 1997;88:302-9.
33. Magnani C, Agudo A, Gonzalez CA, et al. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer. 2000;83:104-11.
34. Magnani C, Dalmasso P, Biggeri A, et al. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect. 2001;109:915-9.
35. Maule MM, Magnani C, Dalmasso P, et al. Modeling mesothelioma risk associated with environmental asbestos exposure. Environ Health Perspect. 2007;115:1066-71.
36. Vianna NJ, Polan AK. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet. 1978;1:1061-3.
37. Chahinian AP, Pajak TF, Holland JF, Norton et al. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746-55.
38. Kilburn KH, Lilis R, Anderson HA, et al. Asbestos disease in family contacts of shipyard workers. Am J Public Health. 1985;75:615-7.
39. Strickler HD, Goedert JJ, Devesa SS, Lahey J, Fraumeni JF, Jr., Rosenberg PS. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst. 2003;95:38-45.
40. Health and Safety Commission. Health and Safety Statistics 1998/99. Sudbury: HSE Books; 1999.
41. Australian Safety and Compensation Council. Preparing an Estimate of the National Pattern of Exposure to Asbestos in Cases of Malignant Mesothelioma. Australian Government Department of Education, Employment and Workplace Relations; 2008 June.
42. Mirabelli D, Stura A, Gangemi M, Bertolotti M, Maule MM, Magnani C. [Incidence of malignant mesothelioma in Piedmont, 1990-2001]. Epidemiologia e prevenzione. 2007;31:132-8.
43. Roggli VL, Oury TD, Moffatt EJ. Malignant mesothelioma in women. Anat Pathol. 1997;2:147-63.
44. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26:55-65.
45. World War II in the San Francisco Bay Area [Internet]. National Park Service, US Department of the Interior; n.d. Tending the Home Front: The Many Roles of Bay Area Women During WWII [cited 2009 Feb 27]. Available from: http://www.nps.gov/history/Nr/travel/wwIIbayarea/womenatwar.htm.
46. Hassan A. Shipyard Day Care Centers of World War II: The Kaiser Experiment 2009 [Internet].[cited 2009 April 2]. Available from: http://wwiishipyarddaycare.tripod.com/intro.htm.
47. Wikipedia [Internet]. Wikimedia Foundation. [2009]. Asbestos [cited 2009 February 20]. Available from: http://en.wikipedia.org/wiki/Asbestos/.
48. Greenberg M. Asbestos Exposures to Women. Personal Communication to: David Egilman. 2009.
49. Brown DP, Dement JM, Okun A. Mortality patterns among female and male chrysotile asbestos textile workers. J Occup Med. 1994;36:882-8.
50. Merewether ERA, Price CW. Report on the Effects of Asbestos Dust on the Lungs and Dust Suppression in the Asbestos Industry. HM Stationary Office; 1930.
51. Finkelstein MM. A study of dose-response relationships for asbestos associated disease. Br J Ind Med. 1985;42:319-25.
52. Saldivar A, Soto V. Asbestos in the United States: Occurrences, Use and Control 2008 [Internet]. Proquest; 2008. [cited 2009 February 26]. Available from: http://www.csa.com/discoveryguides/asbestos/review.pdf.
53. Roggli V. Deposition. Ralph Stanley vs. Anderson et al., Civil Action No. 03-C-9600, Kanawa County, WV; 2005:80.
54. Schneider A. U.S. imports of asbestos brake material are on rise. St Louis Post Dispatch. 2003 Oct 26.
55. Seminario P. Testimony Before the Senate Employment and Worker Safety Subcommittee of Health, Education, Labor and Pensions Committee Hearing on "Is OSHA Working for Working People." 2007 April 26. Available from: http://www.aflcio.org/issues/safety/upload/SeminarioOSHA20070426.pdf.
56. Morton S. Deposition Testimony. Morton vs Owens Illinois et al, Newport News Virginia. 2006.
57. United States Congress. Hearing Transcript. Oversight Of The Navy Department's Enforcement Of OSHA; 1983.
58. Glass A. (President, Steelworkers Union, Newport News Shipyard) Personal Communication to: Robert Hatten R; 2009.
59. Harries PG. Asbestos dust concentrations in ship repairing: A practical approach to improving asbestos hygiene in naval dockyards. Ann Occup Hyg. 1971;14:241-54.
60. Garcia A. OSHA Violations Indicate Enforcement of Asbestos Standard [Internet] Future Environment Designs; 2008 September 05 [cited 2009 Feb 20]. Available from: http://futureenv.blogspot.com/2008/09/osha-violations- indicateenforcement-of.html
61. Saltzman J. Trainer in asbestos removal convicted. Boston Globe. 2008 November 21.
62. Oversight Report: OSHA's Failure To Monitor And Enforce Asbestos Regulations In Auto Repair Shops. Washington, DC: U.S. House of Representatives, Congressman Dennis Kucinich; 2004 Mar. [cited 2008 Feb 2]. Available from: http://kucinich.house.gov/UploadedFiles/OSHA.pdf.)
63. Haque AK, Hernandez JC, Dillard EA, 3rd. Asbestos bodies found in infant lungs. Arch Pathol Lab Med. 1985;109:212.
64. Haque AK, Vrazel DM, Uchida T. Assessment of asbestos burden in the placenta and tissue digests of stillborn infants in South Texas. Arch Environ Contam Toxicol. 1998;35:532-8.
65. Ampleford EJ, Ohar J. Mesothelioma: You do not have to work for it. Diagn Cytopathol. 2007;35:774-7.
66. Barton H, Cogliano J, Firestone M, et al. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F. 2005 March. Available from: http://www.epa.gov/ttn/atw/ childrens-supplement-final.pdf.
67. Lee GL. Removing Dust From Brakes Assemblies During Vehicle Servicing- Alternative Cleaning Methods. Annals Occup Hyg. 1970;13:33-6.
68. Boillat MA, Lob M. Risque d'asbestose chez les travailleurs occupes a remplacer les garniture de freins [Risk of asbestosis in workers employed in replacing automobile brake linings]]. Schweiz Med. 1973;103:1354-9.
69. Castleman B, Ziem G. Control Technology for Brake and Clutch Work. In: Castleman B, ed. Asbestos: medical and legal aspects. 5th ed. New York: Aspen Publishers; 1985.
70. Hatch D. Possible Alternatives to Asbestos as a Fraction Material. Ann Occup Hyg. 1970;13:25-9.
71. Rodelsperger K, Jahn H, Bruckel B, et al. Asbestos Dust Exposure During Brake Repair. Am J of Indust Med.1986;10:63-725.
72. Kauppien T, Korhonen K. Exposure to Asbestos During Brake Maintenance of Automotive Vehicles by Different Methods. Am Ind Hyg Assoc J. 1987;48:499-504.
73. Hickish DE. Exposure to Asbestos Dust during Brake Maintenance Operations on Commercial Vehicles, Fleet Repair Garage, Dagenham. Report 41/68. 1968 October. Produced by Ford in Coates. Plaintiff Exhibit FD5036, http://www.egilman.com/Documents//Asbestos/Brakes/Ford/amosite%20and%2 0brakes/hickish%20amosite%20and%20brakes.pdf
74. Hickish DE. Exposure to Asbestos during the Servicing of Brake of Passenger Cars. Report 52/68. Produced by Ford in Coates. Plaintiff Exhibit FO-55. Available from: http://www.egilman.com/Documents//Asbestos/Brakes/Ford/ Knowledge%20of% 20Excess%20Exposures/ hickish%20secret%20october%20amosite%201968.pdf.
75. Clark AR. Asbestos Exposure Associated with Automotive Brakes Systems. Union Carbide Internal Correspondence. 1976 July 8. 77. Hatfield RL, Longo WE. Bendix Brakes for Chrysler Vehicles: Work Practice Simulation Demonstration. Suwanee, GA: Materials Analytical Services, Inc; n.d.
76. Hatfield RL, Longo WE. Bendix Brakes for Ford Vehicles: Work Practice Simulation Demonstration. Suwanee, GA: Materials Analytical Services, Inc; n.d.
77. Hatfield R, Longo W. Arc Grinding II Cleanup. Raleigh, NC: Materials Analytic Services, Inc.; 2000.
78. Hatfield N, Longo W, Newton LR. Arc Grinding of Brake Shoes: Work Practice Study. Raleigh, NC: Materials Analytical Services, Inc.; 2000.
79. Hatfield N, Longo W, Newton LR. Hand Grinding of Brake Shoes: Work Practice Study. Raleigh, NC: Materials Analytical Services, Inc.; 2000.
80. Hatfield N, Newton LR, Longo W. Hand Sanding of Brake Shoes: Work Practice Study. Raleigh, NC: Materials Analytical Services, Inc.; 2001.
81. Rohl AN, Langer AM, Klimentidis R, et al. Asbestos content of dust encountered in brake maintenance and repair. Proc R Soc Med. 1977;70:32-7.
82. Osborn SH. Forty-Ninth Report of the State Department of Health for the Year Ended June 30, 1934. State of Connecticut Public Document No. 25. Hartford, CT: Bureau of Occupational Diseases; 1934.
83. Roberts DR, Zumwalde RD. Industrial Hygiene Summary Report of Asbestos exposure assessment for brake mechanics. Cincinnati, OH: Industrial Hygiene Section, Industrywide Studies Branch, Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health; 1982 November 22. Report No.: 32.4.
84. Lloyd JW. Current Intelligence Bulletin 5: Asbestos: Asbestos exposure during servicing of motor vehicle brake and clutch assemblies. Cincinnati, OH: National Institute for Occupational Safety and Health; 1975 Aug 8. Available from: http://www.cdc.gov/NIOSH/78127-5.html
85. Longo WE, Mount MD, Hatfield RL. Occupational Exposure to Asbestos-Containing Brake Shoes During Hand Grinding and Sanding. Raleigh, NC: Materials Analytical Services, Inc.; 2004.
86. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565-601.
87. Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008;38 Suppl 1:49-73.
88. Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38 Suppl 1:1-47.
89. Kane A. (Chair, SAB Asbestos Committee). Letter to Johnson S. (EPA Adminstrator), SAB Consultation on EPA's Proposed Approach for Estimation of Bin-Specific Cancer Potency Factors for Inhalation Exposure to Asbestos Cancer Potency Factors for Inhalation Exposure to Asbestos 2008. EPA-SAB-09-004 Available from: http://yosemite.epa.gov/sab/sabproduct.nsf/ 77CFF6439C00ABF3852575010077801F/$File/EPA-SAB-09-004-unsigned.pdf.
90. Selikoff IJ, Seidman H. Asbestos-associated deaths among insulation workers in the United States and Canada, 1967-1987. Ann N Y Acad Sci. 1991;643:1-14.
91. Rogers A, Major G. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure: The Wittenoom data. Ann Occup Hyg 2002;46:127-8; author reply 8-9.
92. Gibbs G, LaChance M. Dust-fiber relationships in the Quebec chrysotile industry. Arch Environ Occup Health. 1974;28:3.
93. Shapiro HA. Pneumoconiosis; Proceedings of the international conference, Johannesburg, 1969. Cape Town, New York,: Oxford University Press; 1970.
94. Hodgson J, Darnton A. Letter. Ann Occup Hyg. 2001;45:336-8.
95. Leigh J, Robinson B. The history of mesothelioma in Australia 1945-2001. In: Robinson B, Chahinian A, eds. Mesothelioma. London: Martin Dunitz; 2000:55-86.
96. Henderson DW. Supplementary Report, On Causation, for Mr. Frank Gregory Lansley. Adelaide, South Australia; 2006 February 27.
97. Costas E, Garrido A, Goyanes VJ. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med. 1998;339:1000; author reply 1-2.
98. Hein MJ, Stayner LT, Lehman E, Dement JM. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med. 2007;64:616-25.
99. Peto J, Rake C, Gilham C, Hatch J. Occupational, domestic and environmental mesothelioma risks in Britain: A case-control study. Health and Safety Executive; 2009. Research Report No.: 696. Available at: http://www.hse.gov.uk/research/rrpdf/rr696.pdf.
100. Paustenbach D. Deposition Testimony. Gray vs.John Crane, Inc., et al. , Virginia Circuit Court for the City of Newport News, Case Number CL0800724PT; 2009 Apr 6.
101. Pierce JS, McKinley MA, Paustenbach DJ, Finley BL. An Evaluation of Reported No-Effect Chrysotile Asbestos Exposures for Lung Cancer and Mesothelioma, Crit Rev Tox. 2008; 38;191-214.
102. Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001;39:150-60.
103. Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ. 1980:237-46.
104. Dodson RF, Williams MG, Jr., Corn CJ, et al. A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann N Y Acad Sci. 1991;643:53-60.
105. LeBouffant L. Investigation and analysis of asbestos fibers and accompanying minerals in biological materials. Environ Health Perspect. 1974;9:149-53.
106. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers. Annals NY Acad Sci. 1991;643:25.
107. Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: Pathological evidence. Int J Hyg Environ Health. 2005;208:201-10.
108. Boutin C, Dumortier P, Rey F, et al. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med. 1996;153:444-9.
109. Müller KM, Schmitz I, Konstantinidis K. Black spots of the parietal pleura: morphology and formal pathogenesis. Respiration. 2002;69:261-7.
110. Mitchev K, Dumortier P, De Vuyst P. 'Black Spots' and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol. 2002;26:1198-206.
111. Wagner JC, Berry G. Mesotheliomas in rats following inoculation with asbestos. Br J Cancer. 1969;23:567-81.
112. Wagner JC, Berry G, Timbrell V. Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer. 1973;28:173-85.
113. Pott F, Huth F, Friedrichs KH. Tumorigenic effect of fibrous dusts in experimental animals. Environ Health Perspect. 1974;9:313-5.
114. Wagner JC, Berry G, Skidmore JW, et al. The effects of the inhalation of asbestos in rats. Br J Cancer. 1974;29:252-69.
115. Appel JD, Fasy TM, Kohtz DS, et al. Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci USA. 1988;85:7670-4.
116. Adamson IY, Bakowska J, Bowden DH. Mesothelial cell proliferation: a nonspecific response to lung injury associated with fibrosis. Am J Respir Cell Mol Biol. 1994;10:253-8.
117. Adamson IY. Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies. Environ Health Perspect 1997;105 Suppl 5:1205-8.
118. Kumar-Singh S, Weyler J, Martin MJ, Vermeulen PB, Van Marck E. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. J Pathol. 1999;189:72-8.
119. DeLong P, Carroll RG, Henry AC, et al. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biol Ther. 2005;4:342-6.
120. Yoshimoto A, Kasahara K, Saito K, Fujimura M, Nakao S. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines. Int J Clin Oncol. 2005;10:58-62.
121. Hegmans JP, Hemmes A, Hammad H, et al. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J. 2006;27:1086-95.
122. Roggli VL, Vollmer RT. Twenty-five years of fiber analysis: what have we learned? Hum Pathol. 2008;39:307-15.
123. Sebastien P, Masse R, Bignon J. Recovery of ingested asbestos fibers from the gastrointestinal lymph in rats. Environ Res. 1980;22:201-16.
124. Acheson ED, Gardner MJ. Mesothelioma and exposure to mixtures of chrysotile and amphibole asbestos. Arch Environ Health. 1979;34:240-2.
125. Roggli VL. Deposition Testimony. Wanda T. Jones, v. Dana Corporation, et al., Circuit Court For The City Of Newport News Virginia, Law No. 39028T-01.; 2006 Jan 13.
126. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26:55-65.
127. Butnor KJ, Sporn TA, Roggli VL. Exposure to brake dust and malignant mesothelioma: a study of 10 cases with mineral fiber analyses. Ann Occup Hyg. 2003;47:325-30.
128. Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases. Mod Pathol. 1995;8:614-21.
129. Roggli VL. Affidavit, Exhibit 1. Bretzke vs. Ford Motor Company, District Court of Ramsey County, Minnesota Court File No. 62CV081189. 2008 Sept 13.
130. Roggli VL. Comments Regarding The U.S. EPA's Proposed Approach for the Estimation of Bin-Specific Cancer Potency Factors for Inhalation Exposure for Asbestos; 2008. http://yosemite.epa.gov/sab/sabproduct.nsf/ 33EEF78BBA9E6D0085257491006E9276/$File/ Asbestos+Public+Comments+Victor+Roggli+July+21-22+2008+Meeting.pdf.
131. Grave Robbers: Chrysler Subpoenas Body At Funeral [Internet]. WCBSTV. 2009 Mar 7. [cited 2009 Mar 14]. Available at: http://wcbstv.com/topstories/ graveside.subpoena.harold.2.952746.html
132. Order on Emergent Application. Harold St. John and Florence St. John v. Affinia Group, Inc., et al. Superior Court of New Jersey Appelate Division. 2009 Mar 18. [cited 2009 Mar 29]. Available from: http://amlawdaily.typepad.com/ stjohnappeal.pdf.
133. Roggli VL. Deposition testimony, Paz vs AW Chesterton et al., Circuit Court, Third Judicial Circuit ,Madison County, Illinois. 1/27/2006
134. Roggli VL. Testimony. Harold R. St. John And Florence Diane St. John vs. Affinia Group, Incorporated, et al., Superior Court Of New Jersey, Law Division: Middlesex County Docket No. Mid-L-5110-08; 2009 Mar 11.
135. Roggli VL. Testimony in Lilly v. John Crane et al, Circuit Court of Newport News, Virginia, Case No. 38861AF. 2001 Sept 19.
136. Roggli VL. The Friction Products Debate (PowerPoint Presentation). Defense Research Institute; 2008 Nov.
137. Egilman DS, Billings MA. Differential peeky bias. Int J Occup Environ Health. 2006;12:294.
138. Roggli VL, McGavran MH, Subach J, et al. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases. Cancer. 1982;50:2423-32.
139. Ingram P, Shelburne JD, Roggli VL. Microprobe analysis in medicine. New York: Hemisphere; 1989.
140. Roggli VL, Longo WE. Mineral fiber content of lung tissue in patients with environmental exposures: Household contacts vs. building occupants. Ann N Y Acad Sci. 1991;643:511-8.
141. Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med. 1986;43:18-28.
142. Roggli VL. Testimony. Robert Frank Smith and Mary Lou Smith v. Chrysler LLC, et al., Los Angeles Superior Court Docket No. 396072. 03/13/2009
143. Work-Related Lung Disease Surveillance Report, 2002. Cincinnati, OH: National Institute for Occupational Safety and Health; 2003. Report No.: 2003-111.
144. Henderson DW. Malignant mesothelioma. New York: Hemisphere Pub. Corp.; 1992.
145. Roggli VL. Questions on your paper response. Email Communication to: David Egilman; 2009 March 17.
146. Roggli VL. Deposition. Windnagle vs Georgia Pacific et al., Circuit Court Of The 11th Judicial Circuit In and For Miami-Dade County Florida CASE NO: 06-28424 CA 42; 2007 Nov 20.
147. Roggli VL. Environmental asbestos contamination: What are the risks? Chest. 2007;131:336-8.
148. Unknown. Regression by Maximum Likelihood Estimation for Left-censored Data [Internet] Available from: http://rss.acs.unt.edu/Rdoc/library/NADA/html/ cenmle.html.
149. Toxicological Profile for Asbestos [Internet]. Agency for Toxic Substances and Disease Registry; 2001 Sept. Available from: http://www.atsdr. cdc.gov/toxprofiles/tp61.html.
150. Roggli VL, Oury TD, Sporn TA. Pathology of asbestos-associated diseases. 2nd ed. New York: Springer; 2004.
151. Environmental Protection Agency. Method for the Determination of Asbestos in Bulk Building Materials. US Environmentqal Protection Agency. 1993 July. Report No.: EPA/600/R-93/116.
152. Environmental Protection Agency. Asbestos Hazard Emergency Response Act. 40 CFR Part 763, Asbestos-containing materials in schools. 1987 October 30.
153. National Institute of Occupational Safety and Health. Asbestos by TEM. NIOSH Manual of Analytical Methods (NMAM), Fourth Edition. 1994 August 15.
154. Standard test method for airborne asbestos concentration in ambient and indoor atmospheres as determined by transmission electron microscopy direct transfer (TEM). ASTM; 1998.
155. Standard Test Method for Microvacuum Sampling and Indirect Analysis of Dust by Transmission Electron Microscopy for Asbestos Structure Number Surface Loading: Dust Sample analysis- ASTM D 5755-03. 2003 Oct 1.
156. Chatfield EJ. Ambient Air, Determination of Asbestos Fibers, Indirect-Transfer Transmission Electron Microscopy Method. International Standard Organization;1999.
157. Chatfield EJ, Berman DW. Interim Superfund Method for the Determination of Asbestos in Ambient Air, Part 1: Method. U.S. Environmental Protection Agency. Publication No: 540/2-90/005a; 1990 May.
158. Loomis D, Dement JM, Wolf SH, et al. Lung Cancer Mortality and Fiber Exposures among North Carolina Asbestos Textile Workers. Occup Environ Med. 2009 Mar 11 [epub ahead of print].
159. Stayner LT. Canada, chrysotile and cancer: Health Canada's asbestos international expert panel report. J Occup Environ Med. 2008;50:1327-8.
160. Roggli VL, Sanders LL. Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg. 2000;44:109-17.
161. Suzuki Y, Yuen SR. Asbestos tissue burden study on malignant mesothelioma. Ind Health. 2001;39:160.
162. Dodson RF, Hammar SP, Poye LW. A technical comparison of evaluating asbestos concentration by phase-contrast microscopy (PCM), scanning electron microscopy (SEM), and analytical transmission electron microscopy (ATEM) as illustrated from data generated from a case report. Inhal Toxicol. 2008;20:723-32.
163. Asbestos in Public and Commercial Buildings:A Literature Review and Synthesis of Current Knowledge. Cambridge, MA: Health Effects Institute, 1991.
164. Finkelstein MM. Asbestos fibre concentrations in the lungs of brake workers: another look. Ann Occup Hyg. 2008;52:455-61.
165. Roggli VL, Sporn TA, Case BW, et al. Comments on Asbestos fibre concentrations in the lungs of brake workers: another look. Ann Occup Hyg. 2009;53:191; author reply 2-3.
166. Gustavsson P, Ahlbom A, Andersson T, et al. Calculation of fractions of lung cancer incidence attributable to occupational exposure to asbestos and combustion products in Stockholm, Sweden. Eur J Epidemiol. 2003;18:937-40.
167. Gustavsson P, Albin M. Low-dose occupational exposure to asbestos and lung cancer risk. Med Lav. 2006;97:357.
168. Stayner L, Kuempel E, Gilbert S, et al. An epidemiological study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med. 2008;65:613-9.
169. Stayner L, Smith R, Bailer J, et al. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med. 1997;54:646-52.
170. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86:179-86.
171. Chen WJ, Mottet NK. Malignant mesothelioma with minimal asbestos exposure. Hum Pathol. 1978;9:253-8.
172. Iwatsubo Y, Pairon JC, Boutin C, et al. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Am J Epidemiol. 1998;148:133-42.
173. Keeton P, Prosser WL. Prosser and Keeton on the law of torts. 5th ed. St. Paul, Minn.: West Pub. Co.; 1984.
174. Hickish DE, Knight KL. Report 41/68: Exposure to Asbestos during the Servicing of Brakes of Passenger Cars. In; 1968.
175. Cline W. Borg Warner Corporation answers to interrogatories in Re: All Asbestos Litigation Borg. In: In The Circuit Court Of The Third Judicial Circuit Madison County, Illinois; 2006.
176. Jenkins W. Maremont answers to interrogatories in the case of London vs. Flintcote et al. Circuit Cort of Pleas case no. 6849 Philadelphia County, Pa. In; 1984.
177. North American Asbestos Corporation Annual Report. 1957. Available from: http://www.egilman.com/browse.php?display=list&dir=Asbestos/Brakes/ amphibole-use/.
178. NorthAmerican Asbeestos Company Customer List. 1976. Available from: http://www.egilman.com/browse.php?display=list& dir=Asbestos/Brakes/ amphibole-use/.
179. Blau PJ. Compositions, Functions, and Testing of Friction Brake Materials and Their Additives: Bechtel; 2001.
180. McDonald J. Linear Extrapolation for Risk Estimation as Low Level Exposure: The Asbestos Example In: London Univ; McGill Univ; Natl Heart + Lung Inst: Philip Morris; Unknown.
181. Greenland S. Relation of probability of causation to relative risk and doubling dose: a methodologic error that has become a social problem. Am J Public Health. 1999;89:1166-9.
182. Egilman D, Howe S. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology. Int J Occup Environ Health. 2007;13:118-24.
183. Henderson DW. Malignant mesothelioma. New York: Hemisphere Pub. Corp.; 1992.
184. Wagner JC, Pooley FD. Mineral fibres and mesothelioma. Thorax. 1986;41:161-6.
185. Churg A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest.1988;93:621-8.
186. Egilman DS, Kim J, Biklen M. The Use and Abuse of Medical and Scientific Evidence Inside the Courtroom-An Epidemiologist's Critique of the Judicial Interpretation of the Daubert Ruling. Food and Drug Law Journal. 2003;58.
187. Rodelsperger K, Woitowitz HJ, Bruckel B, et al. Dose-response relationship between amphibole fiber lung burden and mesothelioma. Cancer Detect Prev. 1999;23:183-93.